TC Group Cayman Investment Holdings, L.P. filed a Form 4 with the SEC on November 19, 2026, disclosing two conversion transactions in Medline Inc. (NASDAQ:MDLN) shares on November 17 and November 18, 2026.
Key Highlights
- November 17 conversion: 3,225,824 Common Units of Medline Holdings, LP were exchanged for an equivalent number of Class A Common Stock shares, acquired by two entities: 699,037 units via CP Circle UNLV Holdco, L.P. and 2,526,787 units via CP Circle ML-1 Holdco, L.P.
- November 18 conversion: An additional 483,874 Common Units were exchanged for Class A Common Stock shares under the same exchange agreement.
- Class A holdings after transactions: The reporting person reported indirect beneficial ownership of 129,163,939 shares of Class A Common Stock following the November 18 transaction.
- Class B holdings reduced: Class B Common Stock held indirectly fell from 61,629,472 (implied prior) to 57,919,774 shares after both transactions, reflecting one-for-one cancellation upon conversion.
- Exchange agreement basis: The conversions were made pursuant to an exchange agreement dated December 16, 2025, which grants holders the right to exchange Common Units for Class A Common Stock on a one-for-one basis with no expiration.
- Reporting entity: TC Group Cayman Investment Holdings, L.P. is identified as a 10% owner of Medline Inc., with The Carlyle Group Inc. sitting at the top of the ownership chain.
Carlyle-Linked Entity Converts Medline Holdings Units to Class A Shares
According to the filing, TC Group Cayman Investment Holdings, L.P., a Cayman Islands-based entity indirectly controlled through The Carlyle Group Inc., reported two separate conversion transactions in Medline Inc. shares. On November 17, 2026, 3,225,824 Common Units of Medline Holdings, LP were exchanged for an equal number of shares of Class A Common Stock, using transaction code "C" (conversion). Simultaneously, 3,225,824 shares of Class B Common Stock were disposed of using transaction code "J," consistent with the filing's explanation that one share of Class B Common Stock is issued for each Common Unit held and is cancelled upon conversion.
A second set of conversions occurred on November 18, 2026, involving 483,874 Common Units exchanged for 483,874 shares of Class A Common Stock, with a corresponding disposal of 483,874 Class B shares. The filing states the price of the derivative security was $0 for both conversion events. Following these transactions, the reporting person's indirect beneficial ownership stood at 129,163,939 shares of Class A Common Stock and 57,919,774 shares of Class B Common Stock, all held indirectly through a network of affiliated limited partnerships and holding companies detailed in the filing's footnotes.
The filing identifies six reporting persons in total: TC Group Cayman Investment Holdings, L.P.; Carlyle Holdings II GP L.L.C.; Carlyle Holdings II L.L.C.; TC Group Cayman Investment Holdings Sub L.P.; TC Group VII, L.L.C.; and TC Group VII, L.P. All are described as 10% owners and directors of Medline Inc. The filing notes that Class B Common Stock "have no economic value and have one vote per share," and that the exchange rights under the December 16, 2025 agreement "do not expire."
What Was Disclosed
TC Group Cayman Investment Holdings, L.P. and affiliated Carlyle entities disclosed the conversion of a combined 3,709,698 Medline Holdings, LP Common Units into an equal number of Medline Inc. Class A Common Stock shares across two dates in November 2026, with corresponding reductions in Class B Common Stock holdings.



Please wait processing your request...